The Biosimilar Forum 2026 brings together industry experts, partners, and innovators to discuss the evolving role of biosimilars in expanding access to biologic treatments.

Hosted at mAbxience’s manufacturing site in León, the forum will explore the scientific, manufacturing, and regulatory challenges shaping the present and future of biosimilars, while fostering dialogue across the biopharmaceutical ecosystem.